Kontafarma China Holdings Limited (HKG:1312)
Hong Kong
· Delayed Price · Currency is HKD 0.0290
0.00 (0.00%)
Apr 29, 2026, 3:55 PM HKT
Kontafarma China Holdings Market Cap
Kontafarma China Holdings has a market cap or net worth of 162.07 million as of April 29, 2026. Its market cap has increased by 7.41% in one year.
Market Cap
162.07M
Enterprise Value
222.68M
Revenue
914.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since January 18, 2012, Kontafarma China Holdings's market cap has decreased from 719.40M to 162.07M, a decrease of -77.47%. That is a compound annual growth rate of -9.91%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PuraPharm Corporation | 157.84M |
| Joyzyme Group | 164.95M |
| Regent Pacific Group | 178.01M |
| Tianda Pharmaceuticals | 208.55M |
| Extrawell Pharmaceutical Holdings | 214.60M |
| Shenzhen Neptunus Interlong Bio-technique Company | 218.14M |
| Qianhai Health Holdings | 69.47M |
| Wai Yuen Tong Medicine Holdings | 384.46M |